Dr. Scott Irvin Bearman MD
Hematologist-Oncologist | Hematology & Oncology
1800 Williams St Suite 300 Denver CO, 80218About
Dr. Scott Bearman is a hematologist oncologist practicing in Denver, CO. Dr. Bearman specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Tufts Univ Sch of Med, Boston Ma 1981
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
- Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant.
- Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
- Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support.
- A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant.
- Veno-occlusive disease of the liver.
- Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation.
- High-dose chemotherapy for breast cancer: we have not heard the final word.
- High-dose chemotherapy for breast cancer.
- Peripheral blood stem cell transplantation in breast cancer.
- Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.
- Avoiding hepatic veno-occlusive disease: what do we know and where are we going?
- Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
- Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer.
- Renal dysfunction in allogeneic hematopoietic cell transplantation.
Clinical Trials
- Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression
- Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant
- Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
- Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor
Dr. Scott Irvin Bearman MD's Practice location
Denver, CO 80218Get Direction
Dr. Scott Irvin Bearman MD's reviews
Write ReviewPatient Experience with Dr. Bearman
Recommended Articles
- The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
- Overcoming Lymphoma: A South Philly Student's Story
In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...
- A Triathlon for Bloodwise
Where would anyone be without friends? There have been many experiences where friends have been a bit of light in the dark. When 30-year-old Alexandra “Pixie” Flather from a town near Aylsham, England found out that her best friend was diagnosed with Leukemia, she decided to take action. At the...
- The Link Between Melatonin and Lymphoma
There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
- Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey
While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...
Nearby Providers
- Dr. Lisa Ahrendt MD1825 N Marion St Denver CO 80218
- Dr. Allen L Cohn MD1800 Williams St Denver CO 80218
- Dr. Michele L Basche MD1800 WILLIAMS ST DENVER CO 80218
- Dr. Jeffrey Victor Matous MD1800 Williams St Denver CO 80218
- Dr. Martin Joseph Rubinowitz MD1960 Ogden St Denver CO 80218
- Dr. Deborah R Cook M.D.1825 Marion St Denver CO 80218